Straumann Holding Ag · SIX:STMN

Straumann — Q3 2020 Earnings Presentation

18 slides from Straumann's earnings presentation, Oct 29, 2020

  1. Slide 1: 2020 nine-month & third-quarter sales

    2020 nine-month & third-quarter sales Webcast for investors, analysts & media Basel, 28 October 2020 1 Disclaimer This presentation contains certain forward-looking statements that reflect the current views of management. Such statements are subject to known and unknown risks, uncertainties and othe

  2. Slide 2: Agenda

    Agenda Highlights Business and regional review Strategy in action Outlook Q&A 3 Highlights Guillaume Daniellot, CEO 4 2

  3. Slide 3: An especially uncertain outlook (OECD)

    “An especially uncertain outlook” (OECD) OECD World GDP Forecast September 20201 Degree of restrictions Dentists open 110 Nov 19 Europe Europe 105 APAC APAC 100 Sep 20 NAM NAM LATAM LATAM 95 Emerging mkts Emerging mkts 90 Patient flow 85 2019-Q4 2020-Q2 2020-Q4 2021-Q2 2021-Q4 Europe World GDP, inde

  4. Slide 4: Group highlights 9M & Q3

    Group highlights 9M & Q3 NINE-MONTH REVENUE DRIVERS REGIONS CHF 976 million Practices open Reachingimprovement Continued patients 9M: -15% in CHF; -11% organic Pent-up demand for restorative, Q3: double-digit growth in APAC; solid Q3: 0% in CHF; +8% organic implant & aligner treatments; strong incre

  5. Slide 5: Q3 rebound only partially offsets first-half shortfall

    Business and regional review Peter Hackel, CFO 9 Q3 rebound only partially offsets first-half shortfall Revenue development (in CHF million, rounded) -15.3% in CHF Regional contribution Revenue -10.7% to revenue decrease development organic Change in organic growth -11.5% -9.2% -7.3% -21.3% 10 10 5

  6. Slide 6: Growth returns in EMEA & North America

    Growth returns in EMEA & North America EMEA Revenue change (organic)  Italy & Spain rebound strongly; France 56% & Germany post moderate increases; dynamic progress in Turkey & Russia 40% of Group  UK, Portugal & Middle East struggle  Clear-aligner production starts in Europe; Artis Bio Tech busi

  7. Slide 7: APAC steams ahead; LATAM clawing its way back

    Growth returns in EMEA & North America EMEA Revenue change (organic)  Italy & Spain rebound strongly; France 56% & Germany post moderate increases; dynamic progress in Turkey & Russia 40% of Group  UK, Portugal & Middle East struggle  Clear-aligner production starts in Europe; Artis Bio Tech busi

  8. Slide 8: Q3 performance by business

    Q3 performance by business Digital & Implant systems Biomaterials Orthodontics restorative 15 15 Strategy in action Guillaume Daniellot, CEO 16 8

  9. Slide 9: Overarching strategic priorities

    Overarching strategic priorities I. Drive our high-performance Straumann Group culture & organization II. Accelerate growth in core implant market & strategic segments III. Create the leading ecosystem for esthetic dentistry 17 17 Overarching strategic priorities I. Drive our high-performance Straum

  10. Slide 10: Mindset for a high-performance culture

    Mindset for a high-performance culture PLAYER  FIXED MINDSET « Let’s collaborate, learn (KNOWER-VICTIM) and win together! » LEARNER KNOWER GROWTH MINDSET (PLAYER-LEARNER)  « I told you. I knew it won’t work! » VICTIM 19 19 Player-learner agility – examples in Q3  Major international congresses ca

  11. Slide 11: #Together Strong – building lasting partnerships with customers

    #Together Strong – building lasting partnerships and networks with customers in a changing environment  New DSO partnerships built in all regions during lock-down  Close collaboration with DSOs in T&E and digital transformation support their bounce-back  Global DSO virtual summit: >50 CEOs from l

  12. Slide 12: Driving the premium implant segment

    Driving the premium implant segment  Smile in a Box™ connects products & services for unmatched customer experience: peace of mind, workflow efficiency, shorter time to teeth  BLX now in >30 countries, gaining market share; further launches in APAC in coming months  New TLX implant combining prov

  13. Slide 13: TLX combining immediacy with tissue-level benefits

    TLX combining immediacy with the proven benefits of Straumann's tissue-level implant system  Immediacy for shorter treatment times  Peri-implant health preservation  Fully integrated in digital workflows  Reduced surgical procedures  Limited market release expected H1 2021 25 25 Becoming a lead

  14. Slide 14: Straumann Group digital solutions: a seamless ecosystem

    Overarching strategic priorities I. Drive our high-performance Straumann Group culture & organization II. Accelerate growth in core implant market & strategic segments III. Create the leading ecosystem for esthetic dentistry 27 27 Straumann Group digital solutions: a unique powerful seamless ecosyst

  15. Slide 15: Leading-edge technology in clear aligners

    Leading-edge technology in clear aligners Full integration of TRIOS intra-oral scanners  Seamless connection with ClearCorrect’s Doctor Portal to facilitate case submission and ordering. Upgraded software tool ClearPilot  Enhanced convenience & time-savings in treatment planning High-perfomance tr

  16. Slide 16: Outlook – uncertainty continues

    Outlook – uncertainty continues • Group remains cautious about the months ahead in view of concerns about the economy, the rapid increase in infection rates and the fact that pent-up demand have been fully absorbed • Underlying business fundamentals are intact • Group confident to emerge as an even

  17. Slide 17: Calendar of upcoming events

    Silvia Dobry appointed new Head of Corporate Communications Experienced communications professional with international background in pharma and medtech sectors  2017-present: Corporate Affairs International, Biogen Switzerland  2014-2017: Senior Regional Communications Manager, Roche Diagnostics A

  18. Slide 18: Thank you

    straumanng/oup 35 18

Straumann Holding — Q3 2020 Earnings Presentation on 6ix